logo
Select company
Select metric
$ -51.02MEarning Before Interest & Taxes (EBIT)
VS
Market
16
Sector
35
Industry
48
History
-
$ 2.41Close
$ 1.95 - $ 5.35 52-Week Range
Ticker Information

Ticker

CRDF

Company Name

CARDIFF ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARDIFF ONCOLOGY INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRDF - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -51.02M
3/31/2025$ -48.85M
12/31/2024$ -45.43M
9/30/2024$ -42.98M
6/30/2024$ -40.86M
3/31/2024$ -40.23M
12/31/2023$ -41.44M
9/30/2023$ -40.8M
6/30/2023$ -39.64M
3/31/2023$ -38.93M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARDIFF ONCOLOGY INC's latest trailing twelve months (TTM) EBIT stands at $ -16.95M.
  • Over the past 5 years, CARDIFF ONCOLOGY INC's average EBIT has been $ -35.68M.
  • The median EBIT for CARDIFF ONCOLOGY INC during this period was $ -39.19M
  • CARDIFF ONCOLOGY INC reached its highest EBIT over the past 5 years at $ -16.95M.
  • The lowest EBIT recorded by CARDIFF ONCOLOGY INC in the same timeframe $ -51.02M

CARDIFF ONCOLOGY INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
MREO : MEREO BIOPHARMA GROUP PLC $ -50.35MAVTX : AVALO THERAPEUTICS INC $ -48.27MHUMA : HUMACYTE INC $ -48.17MCOYA : COYA THERAPEUTICS INC $ -21.06MVTGN : VISTAGEN THERAPEUTICS INC $ -55.77MABEO : ABEONA THERAPEUTICS INC $ 76.89MABVC : ABVC BIOPHARMA INC $ -2.8MLYEL : LYELL IMMUNOPHARMA INC $ -331.4MCURX : CURANEX PHARMACEUTICALS INC -MNPR : MONOPAR THERAPEUTICS $ -17.31M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

CRDF - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -51.02M

Minimum

Jun 30, 2025

$ -16.95M

Maximum

Sep 30, 2020

$ -35.68M

Average

$ -39.19M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.48M with a standard deviation of $ 130.48M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442M
average$ 28.48M
median$ 847.86K
std$ 130.48M